Literature DB >> 20170763

Systematic characterization by mass spectrometric analysis of phosphorylation sites in IRF-3 regulatory domain activated by IKK-i.

Kiyonaga Fujii1, Shingo Nakamura, Kiyohiro Takahashi, Fuyuhiko Inagaki.   

Abstract

Interferon regulatory factor 3 (IRF-3) is a critical transcription factor that regulates innate immune responses against viral infection. Upon infection, IRF-3 is activated through phosphorylation of Ser/Thr residues in its C-terminal domain by the kinases, IKK-i and/or TBK-1. This phosphorylation triggers IRF-3 to interact with the co-activators to form a complex that activates target genes in the nucleus. However, the phosphorylation sites that determine the active/inactive status of IRF-3, estimated using biochemical methods such as mutagenesis and kinase assays, remain controversial. In the present study, phosphorylated IRF-3 189-427 (IRF-3 189C) was prepared by co-expression with IKK-i and was specifically fractionated into 3 major phosphorylation forms using anion-exchange chromatography. Identification of the phosphorylation sites was performed using systematic mass spectrometry approaches as follows: intact molecular mass analysis by nanoESI-MS, MS survey of phosphopeptides, and targeted MS/MS analysis of LC-MS/MS-based proteomics using a high-resolution Orbitrap mass spectrometer. Phosphorylated IRF-3 189C was clearly identified to exist as a mono-phosphoprotein (at Ser-402), and in two di-phosphoprotein forms (at Ser-386, -402 and Ser-396, -402). Thus, we demonstrated that Ser-386, -396 and -402 are directly phosphorylated by IKK-i in the co-expression system. These results will help provide new insights into the IRF-3 activation mechanism. Copyright 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20170763     DOI: 10.1016/j.jprot.2010.02.009

Source DB:  PubMed          Journal:  J Proteomics        ISSN: 1874-3919            Impact factor:   4.044


  6 in total

1.  Transfected poly(I:C) activates different dsRNA receptors, leading to apoptosis or immunoadjuvant response in androgen-independent prostate cancer cells.

Authors:  Sara Palchetti; Donatella Starace; Paola De Cesaris; Antonio Filippini; Elio Ziparo; Anna Riccioli
Journal:  J Biol Chem       Date:  2015-01-07       Impact factor: 5.157

2.  Structural insights into the functions of TBK1 in innate antimicrobial immunity.

Authors:  Chang Shu; Banumathi Sankaran; Catherine T Chaton; Andrew B Herr; Ashutosh Mishra; Junmin Peng; Pingwei Li
Journal:  Structure       Date:  2013-06-06       Impact factor: 5.006

3.  DUSP1 regulates apoptosis and cell migration, but not the JIP1-protected cytokine response, during Respiratory Syncytial Virus and Sendai Virus infection.

Authors:  Alexa C Robitaille; Elise Caron; Nicolas Zucchini; Espérance Mukawera; Damien Adam; Mélissa K Mariani; Anaïs Gélinas; Audray Fortin; Emmanuelle Brochiero; Nathalie Grandvaux
Journal:  Sci Rep       Date:  2017-12-12       Impact factor: 4.379

Review 4.  Advances in IKBKE as a potential target for cancer therapy.

Authors:  Min Yin; Xin Wang; Jie Lu
Journal:  Cancer Med       Date:  2019-11-15       Impact factor: 4.452

Review 5.  IκB kinase ε (IKKε): a therapeutic target in inflammation and cancer.

Authors:  Kelly Verhelst; Lynn Verstrepen; Isabelle Carpentier; Rudi Beyaert
Journal:  Biochem Pharmacol       Date:  2013-01-17       Impact factor: 5.858

6.  Characterization of distinct molecular interactions responsible for IRF3 and IRF7 phosphorylation and subsequent dimerization.

Authors:  Louise Dalskov; Ryo Narita; Line L Andersen; Nanna Jensen; Sonia Assil; Kennith H Kristensen; Jacob G Mikkelsen; Takashi Fujita; Trine H Mogensen; Søren R Paludan; Rune Hartmann
Journal:  Nucleic Acids Res       Date:  2020-11-18       Impact factor: 16.971

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.